TMJ Disorders Market Research Report - Forecast till 2027

TMJ Disorders Market: Information By Type (Myofascial Pain, Internal Derangement, Arthritis), Treatment (Medication, Therapies, Surgical Treatment), End User (Hospitals & Clinics, Ambulatory Surgery Center, Research and Academic Institutes) and Region (Americas, Europe, Asia-Pacific, the Middle East & Africa) - Forecast till 2027

ID: MRFR/Pharma/2758-CR | March 2021 | Region: Global | 111 pages

TMJ Disorders Market Overview


Global TMJ Disorders Market was valued at USD 650.07 Million in 2019 and is expected to register a CAGR of 4.18 % during the forecast period of 2020 to 2027.

TMJ disorders are commonly known as temporomandibular joint and muscle disorders. This is a medical condition that causes dysfunction and pain in the jaw joint and the muscles that control jaw movement. It is found to be common in women than men. Factors that drive the market growth are rising introduction and rapid adoption of advanced treatments and easy availability of medicines, increasing prevalence of TMJ disorders, and rise in healthcare spending worldwide.

Market Dynamics

As per the National Institute of Dental and Craniofacial Research in 2018, the prevalence of TMJ disorders is between 5% and 12%, and it is reportedly higher among youngsters. TMJ disorders are the second-most commonly occurring musculoskeletal conditions resulting in pain and disability. The incidence of TMD peaks from the age of 20-40 years, and it is found to be more prevalent in women than men. Moreover, women who use supplemental estrogen or oral contraceptives are more likely to seek treatment for these conditions. Therefore, the rising prevalence of these disorders in these populations is propelling the market growth. Several research studies focused on studying the prevalence of TMJ disorders are anticipated to drive market growth. For instance, a prevalence study was conducted in 2016 among the university students of North Saudi Arabia, which reported a high prevalence rate among these students. Clicking and pain were the most prevalent finding of TMD, with females having more of these symptoms.

Technology has played an important role in TMJ disorders, which is another key contributing factor for market growth. Moreover, the emergence of non-surgical and surgical treatment methods for TMJ disorders has further propelled the market growth. A study published in PubMed in 2016 describes the advancements in tissue engineering for the treatment of TMJ disorders. Tissue engineering approaches have emerged as promising treatment options for musculoskeletal disorders. Although there is no commercial tissue-engineered product currently on the market for treating TMD, several studies have been performed to develop appropriate tools for engineering TMJ tissues. In addition, in February 2020, AIIMS introduced a new patient-specific artificial jaw-joint replacement with 3D printing technology. Such an approach in favor of TMJ disorders is driving the market growth.

Global TMJ Disorders Market Share, By Type, 2019 (%)
TMJ Disorders Market

Source: MRFR Analysis


TMJ Disorders Market Segmentation


Global TMJ Disorders Market, based on Type, is segmented into myofascial Pain, Internal Derangement (ID), and Osteoarthritis. As per the American Family Physician (AFP), TMD affects up to 15% of adults, with high prevalence at 20 to 40 years of age. Common symptoms include jaw pain or dysfunction, headache, earache, and facial pain.


Myofascial pain syndrome is caused by muscle tension, fatigue, or spasm in the masticatory muscles. The research article published by BMC Musculoskeletal Disorders state that the prevalence of myofascial pain is up to 85% of the general population across the world, fueling the growth of the myofascial pain segment. The conservative treatments for myofascial pain, including analgesics, muscle relaxation, modification of parafunctional behavior, and oral appliances, are usually used. Key players are offering advanced medical devices to treat myofascial pain syndrome, helping them expand their product portfolio. For instance, MJ Health is offering FDA approved TMJ NextGeneration Device to alleviate temporomandibular joint disorder (TMJD) pain.


The global TMJ disorders market, based on treatment, segmented into medication, therapies, surgical, and others. The medication segment is further sub-segmented into pain relievers, anti-inflammatories, tricyclic antidepressants, muscle relaxants, and others. The rise in technological advancement and increasing prevalence are driving the growth of the global TMJ disorders market.


Based on end user, the global TMJ disorders market is segmented into hospitals and clinics, ambulatory surgery centers, academic institutes, and others. The global TMJ disorders market has seen the most promising growth in the last few years due to the introduction and rapid adoption of advanced treatments and the easy availability of medicines. The ambulatory surgery centers segment held a high growth rate in the TMJ disorders market owing to cost-effectiveness, and this trend is anticipated to continue over the forecast period.


Global TMJ Disorders Market Share, By Region, 2019 (%)
TMJ Disorders Market


Source: MRFR Analysis


TMJ Disorders Market Regional Analysis


Global TMJ Disorder Market has been segmented on the basis of regions into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas market has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The European TMJ disorder market has been segmented into Western Europe and Eastern Europe. The Western Europe TMJ disorder market has further been classified into Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. The TMJ disorder market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia-Pacific. The Middle East & Africa TMJ disorder market has been divided into the Middle East and Africa. The Americas held the largest share of 49.20% of the TMJ disorder market in 2019. This share can be attributed to the introduction and rapid adoption of advanced treatments in the region.


Europe held the second-largest position in the TMJ disorder market in 2019 owing to the huge spending on healthcare and a well-developed medical industry in the region. Increasing cases of TMJ disorder is leading the market growth in the region. The accessibility to advanced diagnostic and therapeutic options is also playing an important role in the growth of this market. Ongoing research by medical research laboratories and academic institutes are leading to new developments for the effective cure of this disorder.


Asia-Pacific is anticipated to register the highest growth rate over the forecast period from 2020 to 2027. This is owing to the high incidence of TMJ disorder, increased government initiative, and the presence of a large number of pharmaceutical companies. Various initiatives taken by the government to support the healthcare system are also fueling the growth of the regional market. Furthermore, as per the report published at pub med.gov by the Journal of Oral Rehabilitation, TMD pain was found in 14·8% (n = 817) of the Chinese sample from a total number of 5,524 samples. This high prevalence in the Asia-Pacific region is propelling the growth of the regional TMJ disorder market.


The TMJ disorder market in the Middle East & Africa is growing steadily in the past few years. The key factors propelling the growth of this market are the high prevalence of TMJ disorder and funding by private players and government bodies.


TMJ Disorders Market Key Players


The prominent players in the global TMJ Disorders market are Abbott Laboratories, Sun Pharmaceutical Industries Limited, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd, Allergan, Bayer AG, Zydus Cadila, Mylan NV, Novartis International AG, and Jubilant Life Sciences Limited.


Market Segmentation


Global TMJ Disorders Market, By Type



  • Myofascial Pain

  • Internal Derangement

  • Arthritis


Global TMJ Disorders Market, By Treatment



  • Medication

  • Therapies

  • Surgical Treatment

  • Others


Global TMJ Disorders Market, By End User



  • Hospitals & Clinics

  • Ambulatory Surgery Center

  • Research and Academic Institutes

  • Others


Global TMJ Disorders Market, By Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America



  • Europe

    • Western Europe

      • Germany

      • UK

      • France

      • Italy

      • Spain

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia 

    • South Korea

    • Rest of Asia-Pacific



  • Middle East and Africa

    • Middle East

    • Africa




Available Additional Customizations



  • Additional 5 Company Profiles


Intended Audience



  • TMJ disorders Diagnostic and Treatment Companies

  • TMJ disorders Diagnostic and Treatment Service Providers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 650.07 Million
  CAGR   2020-2027: 4.18%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By Type, Treatment and Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Abbott Laboratories, Sun Pharmaceutical Industries Limited, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd, Allergan, Bayer AG, Zydus Cadila, Mylan NV, Novartis International AG, and Jubilant Life Sciences Limited
  Key Market Opportunities

  • advanced diagnostic and therapeutic options
  • Medical research laboratories and academic institutes are leading to new developments
  •   Key Market Drivers

  • Rising introduction and rapid adoption of advanced treatments and easy availability of medicines
  • Increasing prevalence of TMJ disorders
  • Rise in healthcare spending worldwide